相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
Shumpei Yokota et al.
MODERN RHEUMATOLOGY (2010)
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
Norihiro Nishimoto et al.
MODERN RHEUMATOLOGY (2010)
Time to Treatment as an Important Factor for the Response to Methotrexate in Juvenile Idiopathic Arthritis
H. M. Albers et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
Masaaki Mori et al.
MODERN RHEUMATOLOGY (2009)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
Pharmacogenetic relevance of MTHER polymorphisms
Giuseppe Toffoli et al.
PHARMACOGENOMICS (2008)
Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in metho trexate-treated rheumatoid arthritis patients
R. J. H. M. van der Straaten et al.
PHARMACOGENOMICS (2007)
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis
Judith A. M. Wessels et al.
ARTHRITIS AND RHEUMATISM (2007)
Outcome following onset of juvenile idiopathic inflammatory arthritis: II. Predictors of outcome in juvenile arthritis
N Adib et al.
RHEUMATOLOGY (2005)
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis
T Dervieux et al.
ARTHRITIS AND RHEUMATISM (2004)
Prognostic factors for remission in early rheumatoid arthritis:: a multiparameter prospective study
L Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia
C Laverdière et al.
BLOOD (2002)
Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses
W Urano et al.
PHARMACOGENETICS (2002)
分享论文
